Market Cap 7.42M
Revenue (ttm) 890,000.00
Net Income (ttm) -21.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,432.58%
Debt to Equity Ratio 0.18
Volume 237,500
Avg Vol 169,108
Day's Range N/A - N/A
Shares Out 2.32M
Stochastic %K 91%
Beta 0.53
Analysts Sell
Price Target $14.00

Latest News on MYNZ

Mainz Biomed Expands into Switzerland with labor team w

Feb 20, 2025, 8:01 AM EST - 2 months ago

Mainz Biomed Expands into Switzerland with labor team w


Mainz Biomed Announces Stock Split

Nov 29, 2024, 8:45 AM EST - 5 months ago

Mainz Biomed Announces Stock Split


Mainz Biomed Provides Half Year 2024 Corporate Update

Jul 2, 2024, 8:01 AM EDT - 10 months ago

Mainz Biomed Provides Half Year 2024 Corporate Update


Mainz Biomed Reports Results of 2024 Annual General Meeting

May 31, 2024, 5:01 PM EDT - 11 months ago

Mainz Biomed Reports Results of 2024 Annual General Meeting


Mainz Biomed Reports Full Year 2023 Financial Results

Apr 9, 2024, 8:01 AM EDT - 1 year ago

Mainz Biomed Reports Full Year 2023 Financial Results


Mainz Biomed Provides Year-End Corporate Review 2023

Jan 9, 2024, 8:01 AM EST - 1 year ago

Mainz Biomed Provides Year-End Corporate Review 2023